Inventor · disambiguated record
Eileen Geoghegan
Also filed as: GEOGHEGAN EILEEN
2 granted patents·10 pending applications·0 citations·filing 2015–2023
29Inventor score
Top patents by PatentIndex Score
12 records- 0158US2025205375A1Her3 radioimmunotherapy for the treatment of solid cancersACTINIUM PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0255US10376596B2Antimicrobial compositions comprising single domain antibodies and pseudomonas exotoxinUNIV JOHNS HOPKINS·Filed 2018·Granted Aug 13, 2019·0 cites·12 claims
- 0354US2023248855A1Her3 radioimmunotherapy for the treatment of solid cancersACTINIUM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0451US2024390532A1Radioimmunoconjugates targeting grp78 for use in the treatment of cancerACTINIUM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0551US2024216554A1Radioimmunoconjugates directed to nkg2d ligands for the treatment of cancerACTINIUM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0650US2025339571A1Radioimmunoconjugates targeting phosphatidylserine for use in the treatment of cancerACTINIUM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0749US2022143228A1Her3 radioimmunotherapy for the treatment of solid cancersACTINIUM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0848US2024197931A1Radioimmunotherapy directed to ccr8 for depletion of tumor infiltrating regulatory t cellsACTINIUM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0948US2023302168A1Dr5 radioimmunotherapy in the treatment of solid cancersACTINIUM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1048US2023390424A1Trophoblast glycoprotein radioimmunotherapy for the treatment of solid cancersACTINIUM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1147US10010625B2Antimicrobial compositions comprising single domain antibodies and pseudomonas exotoxinUNIV JOHNS HOPKINS·Filed 2015·Granted Jul 3, 2018·0 cites·18 claims
- 1241US2022202967A1Compositions and methods of immunodepletion for the treatment of malignant and non-malignant hematological diseasesACTINIUM PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Eileen Geoghegan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →